2021 Interview With Dr Matthew OConnor

2021 Interview With Dr Matthew OConnor

Author: LongeCity May 7, 2021 Duration: 20:03
Co-Ceo of Underdog Pharmaceuticals discusses the progress in bringing a new biotechnology platform and therapeutic to market.

The conversations in LongeCity interviews go beyond simple summaries, delving into the nuanced work and personal journeys of those driving the field of longevity forward. Each episode features a direct dialogue between a pioneering researcher, policy advocate, or key community figure and the engaged members of the LongeCity.org forum. This structure ensures questions are rooted in practical curiosity and a deep understanding of the scientific and societal landscape. You'll hear detailed discussions on emerging biomedical research, the complexities of navigating regulatory pathways for healthspan technologies, and the real-world challenges of advocacy. The podcast serves as an auditory bridge, connecting dedicated community insight with the experts shaping the future of human health and medicine. It’s a focused exploration for anyone interested in the substantive, often overlooked, conversations happening at the intersection of science, governance, and non-profit work aimed at extending healthy human life. Listen for candid perspectives on both the monumental possibilities and the everyday hurdles in life extension, all captured through these unique, community-driven interviews.
Author: Language: English Episodes: 100

LongeCity interviews
Podcast Episodes
Interview with Alessandra Zonari of One Skin [not-audio_url] [/not-audio_url]

Duration: 20:01
An interview with Alessandra Zonari of One Skin, a skin rejuvenation company. The discussion revolves around their proprietary senolytic skin cream.
Dennis Kowalski Interview [not-audio_url] [/not-audio_url]

Duration: 19:08
Dennis Kowalski, the president of the Cryonics institute, discusses his involvement in cryonics and the cryonics industry in general
2020 Interview with Dr. Matthew O'Connor [not-audio_url] [/not-audio_url]

Duration: 17:39
Dr. Matthew O'Connor talks about founding Underdog Pharmaceuticals and describes their platform technology for using tailored cyclodextrins to remove disruptiive molecules from the body.
Interview with Neil Thanedar of Labdoor [not-audio_url] [/not-audio_url]

Duration: 11:30
Neil Thanedar of Labdoor talks about recent trends in the supplement market, what new categories they have been testing, and what contaminants are most common in most supplements and foods.
Interview with Joao Pedro De Magalhaes [not-audio_url] [/not-audio_url]

Duration: 20:19
Joao Pedro De Magalhaes discusses recent research into genomics and possible translational applications for human rejuvenation.
Interview with Steve Perry [not-audio_url] [/not-audio_url]

Duration: 15:58
GDF-11 is an endogenous peptide with possible rejuvenation properties. In this interview with Steve Perry, find out how his 5 year experiement with GDF-11 has progressed.
Kevin Perrot Longecity Interview (2017) [not-audio_url] [/not-audio_url]

Duration: 13:40
Longecity co-founder Kevin Perrott is once again on the leading edge of moving rejuvenation forward. In this interview, find out what old and new organizations he will be working with.
Interview with Chris Burres of SES Research [not-audio_url] [/not-audio_url]

Duration: 24:03
An interview with Chris Burres of SES Research about C60 as a therapeutic and an upcoming attempt at replicating the original C60 in olive oil (Baati et al) rat study.
RAADfest 2019 Rudi Hoffman [not-audio_url] [/not-audio_url]

Duration: 0:00
Rudi Hoffman briefly explains the logic and affordability of cryonics